levosalbutamol

Other names: levalbuterol

Classifications: 6000

Reasons for prohibition: - [{"reason_code": 6011, "reason": "WADA S3: Beta-2 Agonists", "link": "https://www.wada-ama.org/en/prohibited-list", "guid": "aecafa3b-c7ad-413c-bc5f-be7ed5b2f69d", "link_title": "WADA Prohibited List S3: Beta-2 Agonists", "updated": {"_seconds": 1703682857, "_nanoseconds": 73000000}}, {"reason_code": 6016, "reason": "Prescription drug", "link": null, "guid": "becae72e-580f-4d8d-8665-c0c4b1dc1381", "link_title": null, "updated": {"_seconds": 1703683249, "_nanoseconds": 70000000}}]

References: - {'title': 'NIH NCATS Inxight Drugs entry: Levalbuterol', 'url': 'https://drugs.ncats.io/drug/EDN2NBH5SS'}

Reason: WADA S3: Beta-2 AgonistsPrescription drug

Searchable name: levosalbutamol

GUID: 7c917b1b-cc4d-45ce-b896-b1589f1159db

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1709838391, "_nanoseconds": 298000000}